significantNew research
Colchicine resistance mechanisms linked to pyrin inflammasome microtubule independence
Familial Mediterranean Fever →Summary
Building on Van Gorp et al. (2016) findings, ongoing research clarifies that FMF mutations render pyrin inflammasome activation independent of microtubules, explaining why colchicine — a microtubule disruptor — fails in some patients. Colchicine's clinical efficacy likely operates through leukocyte motility and adhesion rather than direct inflammasome inhibition.
Related treatments
More from Familial Mediterranean Fever
significantTreatment update
JAK inhibitors (tofacitinib) emerging as potential third-line therapy
significantTreatment update
IL-1 blockade established as standard second-line therapy for colchicine-resistant FMF
significantTreatment update
EULAR/PReS 2024 updated management recommendations published
incrementalGenetic finding
SAA1 gene polymorphisms identified as independent amyloidosis risk modifier
ID: familial-mediterranean-fever-update-2Type: new_researchImpact: significant